VAERS reports by lot

GSK Varicella/Shingles lot 2YN4S: VAERS reports

64 VAERS reports list lot 2YN4S as a GSK Varicella/Shingles vaccine, received between 2019-03-17 and 2020-12-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
64
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6427%
General / Systemic (non-local)5423%
Musculoskeletal2912%
Neurological229%
Dermatological (non-injection-site)229%
Gastrointestinal167%
Cardiac / Cardiovascular94%
Allergic / Anaphylactic94%
Respiratory94%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maryland7
Virginia6
Pennsylvania6
Missouri6
New Jersey6
Illinois5
Indiana4
California3
Wisconsin3
Massachusetts2
New York2
Iowa2

Reports by month received

2019-0313
2019-0422
2019-058
2019-069
2019-074
2019-083
2019-091
2019-102
2020-031
2020-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.